Compound Detail
CHEMBL4297730
CONCIZUMAB 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
No structure available
Basic Information
| ChEMBL ID | CHEMBL4297730 |
| Name | CONCIZUMAB |
| Phase | Approved |
| Structure Type | SEQ |
| Therapeutic | ✓ Yes |
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
0
Publications
13
Known Names
3
Indications
1
Mechanisms
Drug Information
| Molecule Type | Antibody |
| First Approval | 2024 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Tissue factor pathway inhibitor inhibitor | INHIBITOR | Tissue factor pathway inhibitor | ✓ | ✓ |
Indications
Hemorrhage Hemophilia A Hemophilia B
ATC Classification
B02BX10
concizumab
Level 1: BLOOD AND BLOOD FORMING ORGANS
Level 2: ANTIHEMORRHAGICS
Data from ChEMBL 36 via Core Engine